Загрузка...
Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research
The armamentarium of therapies for patients with heart failure and reduced ejection fraction (HFREF) has increase substantially with the introduction of Angiotensin Receptor Neprilysin Inhibitor (ARNi), sodium glucose cotransport inhibitors (SGLTis), ivabradine, and Vericinguat, bringing to seven th...
Сохранить в:
| Опубликовано в: : | J Clin Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8122403/ https://ncbi.nlm.nih.gov/pubmed/33919005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10091803 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|